We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
27 Oct 2020 - 31 Oct 2020
Virtual Venue
28 Oct 2020 - 30 Oct 2020
Virtual Venue


Future COVID-19 Tests Could Be Based on Biomarkers and Molecular Profiles of Individuals

A new study has shown how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity. This could pave the way for better medical tests based on biomarkers and molecular profiles of individuals, to accommodate these variations in monitoring virus transmission and disease pathology, which helps guide mitigation and treatment options. More...
23 Oct 2020

New COVID-19 Mass Screening Method Could Be 20 Times Cheaper Than Individual Testing

Using a new mathematical approach to screen large groups for COVID-19 could be around 20 times cheaper than individual testing, suggests a study by researchers at The University of Edinburgh (Edinburgh, UK). More...
22 Oct 2020
BIOHIT  Healthcare OY
Image: BreathTest-1000™ mass spectrometer (Photo courtesy of Business Wire)

Mass Spectrometry-Based Device Uses Breath Samples to Rapidly Identify COVID-19 Strains

Scientists are leveraging mass spectrometry technology to develop a rapid, non-invasive device that will use breath samples to identify COVID-19 strains. More...
22 Oct 2020
Image: The POSTECH researchers designed the test kit to produce nucleic acid binding reaction to show fluorescence only when COVID-19 RNA is present (Photo courtesy of POSTECH)

New Simple, Portable and Easy-To-Use Technology Diagnoses COVID-19 Infection in Just 30 Minutes

A new one-pot diagnostic method for detecting pathogenic RNAs with PCR-level sensitivity allows anyone to easily and quickly diagnose COVID-19 in just 30 minutes. More...
22 Oct 2020

Rapid COVID-19 Antigen Tests Less Effective at Detecting SARS-CoV-2 in People with Low Virus Levels, Finds Study

Researchers from the Erasmus University Medical Center (Rotterdam, the Netherlands) have cautioned that not all rapid COVID-19 antigen tests that provide results within 30 minutes may be equally effective at detecting the SARS-CoV-2 virus. More...
22 Oct 2020
Image: VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit (Photo courtesy of Becton, Dickinson and Company)

CerTest Biotec and BD Secure CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX System

CerTest Biotec (Zaragoza, Spain), along with Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA), have announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit adapted for the BD MAX System has been CE marked. More...
22 Oct 2020
Image: Photomicrograph of histology of a Ewing sarcoma in lung. The PAS stain highlights glycogen and the staining was negative with a PAS diastase stain (Photo courtesy of Nephron).

Comprehensive Molecular Profiling Matches Pediatric Patients to Therapies

A major challenge of using a comprehensive profiling approach for precision medicine is separating pathogenic from non-pathogenic molecular changes within a tumor. More...
22 Oct 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.